Klaus Cichutek (born 26 February 1956 in Recklinghausen) is a German biochemist and the current president of the Paul Ehrlich Institute (PEI).
Cichutek completed his studies of chemistry in 1981 and earned a doctoral degree in biochemistry in 1984, both at the University of Münster.
From 1985 to 1988 Cichutek was affiliated with the Department of Molecular Biology and Virus Laboratory at the University of California, Berkeley.
[1] In addition to his role at PEI, Cichutek chaired the Bundesärztekammer's commission on somatic gene therapy from 2000 to 2010, and the Gene Therapy Working Party of the European Medicines Agency (EMA) from 2003 to 2010.
[2] Since 2020, he has been an ex-officio member of a working group on COVID-19 vaccines established by the Strategic Advisory Group of Experts at the World Health Organization (WHO).